Literature DB >> 3948158

Isolation and characterization of the two subpopulations of cells with different lethalities from Zajdela ascitic hepatoma.

G Pande, D S Joshi, K Sundaram, M R Das.   

Abstract

Two distinct subpopulations of cells, light (L-cells) and heavy (H-cells), have been isolated and characterized from a rat ascitic tumor, the Zajdela ascitic hepatoma. These two populations have been separated by Percoll density gradient centrifugation and studied by flow cytofluorimetry. The two populations, in addition to their difference in buoyant densities, show characteristically different profiles for DNA and RNA contents, nonspecific esterase activity, and surface amino group distribution. The DNA distribution in the two types of cells clearly shows that the H-cells are rapidly proliferating while the L-cells are quiescent. Studies on the two groups of cells after colchicine treatment also confirm this conclusion. The H-cell induced tumors kill the host animals rapidly while the L-cell induced tumors regress in about 3 months. The H- and L-cells from the Zajdela tumor form a convenient experimental system to study the marked difference in the progression of tumors induced by these cells, possible differences in gene expression in regressing and nonregressing tumors and the interactions between the subpopulations with a view to delineate molecular events governing tumor progression and tumor heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948158

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Pattern RT1A and proteasome expression in cellular fractions of Zajdela ascitic hepatoma.

Authors:  V I Melnikova; L A Zakharova; I I Khegai; L N Ivanova
Journal:  Dokl Biochem Biophys       Date:  2014-08-30       Impact factor: 0.788

2.  An efficient targeted drug delivery through apotransferrin loaded nanoparticles.

Authors:  Athuluri Divakar Sai Krishna; Raj Kumar Mandraju; Golla Kishore; Anand Kumar Kondapi
Journal:  PLoS One       Date:  2009-10-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.